Go back

Opportunity profile: Unravelling the mysteries of mRNA


Moderna’s Global Fellowships are for researchers with bold ideas in an array of fields

The US biotechnology firm Moderna is running its Global Fellowship programme for a second round—and once again has a wide remit. Not only is it open to applicants from around the world but it covers a wide array of disciplines—clinical medicine, basic research, epidemiology, pharmacology, and nursing—across a variety of therapeutic areas—infectious diseases (Covid, flu, RSV, CMV, and EBV), immuno-oncology, personalised cancer vaccines, rare diseases, cardiovascular diseases, and autoimmune diseases.

Additionally, the scheme has a rare area of focus in accepting bids from mRNA science, where the firm’s expertise came to prominence following its success with mRNA-based Covid vaccines. (Moderna is currently locked in a legal battle with its competitor Pfizer and its German partner over the technology.)

This article is only available to Research Professional News subscribers. If you are a subscriber you can read the article in full on researchprofessional.com

Pivot-RP users can log in and view the article via this link.